Categories: Wire Stories

Ketamine Clinic in Japan for Inbound Medical Treatment: Nagoya Anesthesia Clinic

NAGOYA, Japan–(BUSINESS WIRE)–Nagoya Anesthesia Clinic (https://nagoyamasui.com/2-2), located in Nagoya City, Aichi Prefecture, Japan, has initiated inbound medical treatment for treatment-resistant depression, other mental disorders, and intractable chronic pain, utilizing the groundbreaking drug Ketamine. Over the past 15 years, the clinic has provided ketamine therapy through more than 1300 ketamine infusions. Our distinctive approach to addressing pain and depression includes a simultaneous cervical epidural block, with successful implementation in over 250 cases, and hypnotherapy during ketamine infusion. Additionally, the clinic offers innovative procedures such as Echo-Guided Botox treatment for stiff neck and Echo-Guided PRP therapy for tennis elbow.


Ketamine, a widely used general anesthetic with a history dating back over 50 years, has also been employed in the United States for the treatment of mental disorders and chronic pain for the past decade. Unlike conventional medications, which may take time to alleviate symptoms, Ketamine offers rapid relief within hours to up to three weeks of administration. Moreover, it is associated with minimal long-term side effects, making it a promising treatment option.

Drawing on their extensive experience of performing Ketamine infusions for various pain and mental disorders, Nagoya Anesthesia Clinic has established the Ketamine Clinic based on Ketamine’s potent analgesic and antidepressant properties. Typically, ketamine infusions are administered in sets of 3 to 6 sessions over a span of 1 to 3 weeks, followed by a maintenance therapy once a month, known for its low incidence of long-term side effects.

Nagoya Anesthesia Clinic is dedicated to provision of exceptional care and innovative treatments to patients in Japan and beyond, welcoming patients for inbound medical treatment of treatment-resistant depression, OCD, PTSD, and intractable chronic pain starting from October 2023. Building on their extensive ketamine infusion experience, the clinic aims to support individuals coping with treatment-resistant conditions through innovative, evidence-based, and compassionate approaches.

 

Contacts

For inquiries, please contact:

JTB Medical & Healthcare:

jmhc_info@j-medical-healthcare.com

Alex

Recent Posts

Wipro Infrastructure Engineering’s Hydraulics Business enters into a definitive agreement to acquire Mailhot Industries

BANGALORE, India--(BUSINESS WIRE)--$WIPRO #AdditiveManufacturing--Wipro Hydraulics, the hydraulic cylinders and components manufacturing business of Wipro Infrastructure…

2 hours ago

Global Nanocomposites Strategic Research Report 2024: Market to Reach $26.8 Billion by 2030 – Tracing Opportunities in the Rapidly Evolving Field of Energy Storage – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Nanocomposites - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.…

2 hours ago

R Systems Launches Groundbreaking Solution at Boomi World 2024 to Revolutionize Supply Chain Management

NOIDA, India--(BUSINESS WIRE)--#AI--R Systems International Limited (a Blackstone portfolio company), a leading digital product engineering…

3 hours ago

Roland Corporation Announces Executive Leadership Changes

Masahiro Minowa Appointed Representative Director and CEO following resignation of Gordon Raison LOS ANGELES--(BUSINESS WIRE)--Roland…

3 hours ago

Global Adipic Acid Strategic Industry Report 2024: Market to Reach $18.2 Billion by 2030, Asia-Pacific Evolves into Most Important Regional Market – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Adipic Acid - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.…

3 hours ago

Generali Hong Kong’s “The Human Safety Net” Unites Student Volunteers in Service to Vulnerable Communities

HONG KONG SAR - Media OutReach Newswire - 9 May 2024 - Generali Hong Kong…

3 hours ago